Papers: 10.1038/s41598-018-27994-x

https://doi.org/10.1038/s41598-018-27994-x

Indirect comparison of efficacy and safety between immune checkpoint inhibitors and antiangiogenic therapy in advanced non–small-cell lung cancer

Cited by: 4
Author(s): Jin Hua Chen, Jia-Lian Yang, Che‐Yi Chou, Jiun Yi Wang, Chin‐Chuan Hung
Published: about 7 years ago

Software Mentions 1